-- Structure Therapeutics (GPCR) has an average rating of Buy and mean price target of $108.50, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
(Corrects period in first paragraph to first quarter of 2026)Ningbo Joyson Electronic (HKG:0699, SHA:600699) recorded an 18% rise in attributable profit in the first quarter of 2026 to 402.1 million yuan from 340.5 million yuan a year prior, according to a Monday Hong Kong bourse filing.Earnings per share increased to 0.26 yuan from 0.24 yuan in the corresponding period of the previous fiscal year.Operating income slipped 5.2% to 13.8 billion yuan from 14.6 billion yuan in the year-ago period.
Ningbo Joyson Electronic (HKG:0699, SHA:600699) recorded an 18% rise in attributable profit in the first quarter of 2025 to 402.1 million yuan from 340.5 million yuan a year prior, according to a Monday Hong Kong bourse filing.Earnings per share increased to 0.26 yuan from 0.24 yuan in the corresponding period of the previous fiscal year.Operating income slipped 5.2% to 13.8 billion yuan from 14.6 billion yuan in the year-ago period.